Akili begins enrolment for STARS-ADHD trial to treat children with ADHD

Akili Interactive Labs (Akili) has begun enrolment for its STARS-ADHD trial, which will evaluate the safety and efficacy of the company’s proprietary platform, Project: EVO, for the treatment of children with Attention Deficit Hyperactivity Disorder …
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news